The oncology pipeline is marked by heterogeneity and complexity (1). Moving forward, pharmaceutical scientists must navigate the intersection of advanced biology, next-generation delivery platforms, ...
Doctors and pharmaceutical experts have raised growing concerns about the shortages in recent months. The American Medical ...
One example detailed in the study is amoxicillin, the second-most-prescribed oral antibiotic in the US. While amoxicillin ...
The agency’s overcaution is enabled by the requirement for ‘substantial evidence,’ not that efficacy is part of the equation.